In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment

被引:0
作者
Csilla Kriston
Márk Plander
Ágnes Márk
Anna Sebestyén
Edina Bugyik
András Matolcsy
Gábor Barna
机构
[1] Semmelweis University,1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine
[2] Markusovszky University Teaching Hospital,Department of Hematology
来源
Annals of Hematology | 2018年 / 97卷
关键词
CD49d; CXCR4; CLL; Microenvironment; Immunophenotype;
D O I
暂无
中图分类号
学科分类号
摘要
CD49d and CXCR4 are key determinants of interactions between chronic lymphocytic leukemia (CLL) tumor cells and their microenvironment. In this study, we investigated the effect of CD49d and CXCR4 expressions on survival of CLL cells. Primary CLL cells were cultured with CD49d ligand, VCAM-1, or bone marrow stromal cells (BMSCs); then, apoptosis and immunophenotype analyses were performed. VCAM-1 treatment could not induce direct apoptosis protection or immunophenotype change on the CD49d-expressing CLL cells, but resulted in actin reorganization. The BMSC-induced apoptosis protection was independent from the presence of CD49d expression of CLL cells, but showed an inverse correlation with their CXCR4 expression level. We suppose that CD49d contributes to enhanced survival of leukemic cells by mediating migration to the protective microenvironment, not by direct prevention of apoptosis. Moreover, CLL cells with low CXCR4 expression represent a subpopulation that is more dependent on the microenvironmental stimuli for survival, and show increased “death by neglect” when separated from the supportive niche.
引用
收藏
页码:2145 / 2152
页数:7
相关论文
共 293 条
[1]  
Chiorazzi N(2005)Chronic lymphocytic leukemia N Engl J Med 352 804-815
[2]  
Rai KR(2014)The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies Semin Cancer Biol 24 71-81
[3]  
Ferrarini M(2014)CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia J Clin Oncol 32 897-904
[4]  
Burger JA(2008)Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia Blood 111 865-873
[5]  
Gribben JG(2008)CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential Br J Haematol 140 537-546
[6]  
Bulian P(2016)CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia Leukemia 30 2011-2018
[7]  
Shanafelt TD(2009)CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival Cancer Res 69 4001-4009
[8]  
Fegan C(2012)The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells Leukemia 26 1301-1312
[9]  
Zucchetto A(2011)Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells PLoS One 6 e23758-556
[10]  
Cro L(2014)Molecular pathways: targeting the microenvironment in chronic lymphocytic leukemia—focus on the B-cell receptor Clin Cancer Res 20 548-374